Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor

Authors

  • Arkadiusz Z. Dudek Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA
  • Pradeep K. Murthaiah Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA
  • Michael Franklin Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA
  • Alexander M. Truskinovsky Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA

DOI:

https://doi.org/10.3109/02841860902913579

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2010-01-01

How to Cite

Dudek, A. Z., Murthaiah, P. K., Franklin, M., & Truskinovsky, A. M. (2010). Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor. Acta Oncologica, 49(1), 102–104. https://doi.org/10.3109/02841860902913579

Issue

Vol. 49 No. 1 (2010): Acta Oncologica

Section

Articles